WIDESPREAD EXPRESSION OF HUNTINGTONS-DISEASE GENE (IT15) PROTEIN PRODUCT

被引:407
作者
SHARP, AH
LOEV, SJ
SCHILLING, G
LI, SH
LI, XJ
BAO, J
WAGSTER, MV
KOTZUK, JA
STEINER, JP
LO, A
HEDREEN, J
SISODIA, S
SNYDER, SH
DAWSON, TM
RYUGO, DK
ROSS, CA
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,NEUROPATHOL LAB,BALTIMORE,MD 21205
[4] JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205
[5] JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL,BALTIMORE,MD 21205
[6] JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205
关键词
D O I
10.1016/0896-6273(95)90345-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's Disease (HD) is caused by expansion of a CAG repeat within a putative open reading frame of a recently identified gene, IT15. We have examined the expression of the gene's protein product using antibodies developed against the N-terminus and an internal epitope. Both antisera recognize a 350 kDa protein, the predicted size, indicating that the CAG repeat is translated into polyglutamine. The HD protein product is widely expressed, most highly in neurons in the brain. There is no enrichment in the striatum, the site of greatest pathology in HD. Within neurons, the protein is diminished in nuclei and mitochondria and is present in the soluble cytoplasmic compartment, as well as loosely associated with membranes or cytoskeleton, in cell bodies, dendrites, and axons. It is concentrated in nerve terminals, including terminals within the caudate and putamen. Thus, the normal HD gene product may be involved in common intracellular functions, and possibly in regulation of nerve terminal function. The product of the expanded allele is expressed, consistent with a gain of function mechanism for HD at the protein level.
引用
收藏
页码:1065 / 1074
页数:10
相关论文
共 58 条
  • [1] BIOTIN AMPLIFICATION OF BIOTIN AND HORSERADISH-PEROXIDASE SIGNALS IN HISTOCHEMICAL STAINS
    ADAMS, JC
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1992, 40 (10) : 1457 - 1463
  • [2] ALTERNATIVE EXCITOTOXIC HYPOTHESES
    ALBIN, RL
    GREENAMYRE, JT
    [J]. NEUROLOGY, 1992, 42 (04) : 733 - 738
  • [3] GENETICS AND MOLECULAR-BIOLOGY OF HUNTINGTONS-DISEASE
    ALBIN, RL
    TAGLE, DA
    [J]. TRENDS IN NEUROSCIENCES, 1995, 18 (01) : 11 - 14
  • [4] STRUCTURE AND EXPRESSION OF THE HUNTINGTONS-DISEASE GENE - EVIDENCE AGAINST SIMPLE INACTIVATION DUE TO AN EXPANDED CAG REPEAT
    AMBROSE, CM
    DUYAO, MP
    BARNES, G
    BATES, GP
    LIN, CS
    SRINIDHI, J
    BAXENDALE, S
    HUMMERICH, H
    LEHRACH, H
    ALTHERR, M
    WASMUTH, J
    BUCKLER, A
    CHURCH, D
    HOUSMAN, D
    BERKS, M
    MICKLEM, G
    DURBIN, R
    DODGE, A
    READ, A
    GUSELLA, J
    MACDONALD, ME
    [J]. SOMATIC CELL AND MOLECULAR GENETICS, 1994, 20 (01) : 27 - 38
  • [5] THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE
    ANDREW, SE
    GOLDBERG, YP
    KREMER, B
    TELENIUS, H
    THEILMANN, J
    ADAM, S
    STARR, E
    SQUITIERI, F
    LIN, BY
    KALCHMAN, MA
    GRAHAM, RK
    HAYDEN, MR
    [J]. NATURE GENETICS, 1993, 4 (04) : 398 - 403
  • [6] REDUCED BASAL GANGLIA VOLUME ASSOCIATED WITH THE GENE FOR HUNTINGTONS-DISEASE IN ASYMPTOMATIC AT-RISK PERSONS
    AYLWARD, EH
    BRANDT, J
    CODORI, AM
    MANGUS, RS
    BARTA, PE
    HARRIS, GJ
    [J]. NEUROLOGY, 1994, 44 (05) : 823 - 828
  • [7] BEAL MF, 1991, J NEUROSCI, V11, P1649
  • [8] DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES
    BEAL, MF
    HYMAN, BT
    KOROSHETZ, W
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (04) : 125 - 131
  • [9] REPLICATION OF THE NEUROCHEMICAL CHARACTERISTICS OF HUNTINGTONS-DISEASE BY QUINOLINIC ACID
    BEAL, MF
    KOWALL, NW
    ELLISON, DW
    MAZUREK, MF
    SWARTZ, KJ
    MARTIN, JB
    [J]. NATURE, 1986, 321 (6066) : 168 - 171
  • [10] BEAL MF, 1993, J NEUROSCI, V13, P4181